Bookbot

NASH, An Issue of Clinics in Liver Disease

Parametri

  • 240pagine
  • 9 ore di lettura

Maggiori informazioni sul libro

Although effective treatments for Non-alcoholic Steatohepatitis (NASH) are yet to be developed, several potentially promising treatment approaches are under investigation. This issue of Clinics in Liver Diseases presents the views of several internationally renowned NAFLD experts on the most up to date epidemiology, natural history, diagnosis, pathogenesis, and treatment of NAFLD. Additionally, this issue presents recent work on to the importance of NAFLD in children, as well as in the individuals who undergo weight reduction surgery. Experts discuss the role of new technologies, such as genomics and proteomics, in understanding NAFLD and developing new biomarkers, including fibrosis markers. Presents recent work on to the importance of NAFLD in children, as well as in the individuals who undergo weight reduction surgery.

Acquisto del libro

NASH, An Issue of Clinics in Liver Disease, Zobair M. Younossi

Lingua
Pubblicato
2007
product-detail.submit-box.info.binding
(Copertina rigida)
Ti avviseremo via email non appena lo rintracceremo.

Metodi di pagamento

Titolo
NASH, An Issue of Clinics in Liver Disease
Lingua
Inglese
Editore
Saunders
Pubblicato
2007
Formato
Copertina rigida
Pagine
240
ISBN10
141604289X
ISBN13
9781416042891
Serie
Descrizione
Although effective treatments for Non-alcoholic Steatohepatitis (NASH) are yet to be developed, several potentially promising treatment approaches are under investigation. This issue of Clinics in Liver Diseases presents the views of several internationally renowned NAFLD experts on the most up to date epidemiology, natural history, diagnosis, pathogenesis, and treatment of NAFLD. Additionally, this issue presents recent work on to the importance of NAFLD in children, as well as in the individuals who undergo weight reduction surgery. Experts discuss the role of new technologies, such as genomics and proteomics, in understanding NAFLD and developing new biomarkers, including fibrosis markers. Presents recent work on to the importance of NAFLD in children, as well as in the individuals who undergo weight reduction surgery.